tiprankstipranks
Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market

Dogwood Therapeutics (DWTX) Income Statement

Compare
185 Followers

Dogwood Therapeutics Income Statement

Last quarter (Q3 2024), Dogwood Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Dogwood Therapeutics's net income was $-2.28M. See Dogwood Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -5.45M$ -12.32M$ -15.97M$ -10.01M$ -2.18M
Operating Income
$ -5.45M$ -12.32M$ -15.64M$ -10.01M$ -2.18M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -5.30M$ -12.25M$ -15.96M$ -10.35M$ -2.47M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis